Unbiased AI-powered news
Wired reviewed three smart rings that monitor activity, sleep, and health metrics. The devices require less frequent charging than most smartwatches and include features such as meal logging and cycle tracking.
WiredWired reviewed three smart rings that track activity, sleep, and health metrics without requiring daily charging. The rings also offer features such as meal logging, AI assistance, and cycle tracking.
The Oura Ring 4 is the top-rated model in the review. It tracks heart rate, body temperature, and blood oxygen levels, and it automatically recognizes activities and analyzes sleep stages. The ring requires a paid subscription for full features. 2 grams depending on size.
Battery life reaches up to eight days, and it is water-resistant to 100 meters. Available colors include silver, black, gold, and ceramic finishes.
The RingConn Gen 2 Air is a subscription-free option priced at $199. It tracks steps, calories, heart rate, blood oxygen, and sleep, and it includes an AI assistant that adjusts weekly targets. 5 and 4 grams. It uses steel construction with a PVD coating.
The Samsung Galaxy Ring is listed as the best option for Samsung device users. It is currently available at a 27 percent discount from its regular price of $400. Wired noted that smart rings have become more affordable and that additional models are expected in the coming months.
Single source — no framing comparison available.
washingtonpost.comFlooding along the Guadalupe River has killed at least one person in central Texas. The same area recorded more than 130 deaths in flash floods last summer. Governor Greg Abbott confirmed the fatality in a Thursday update.
upi.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. Manufactured by Merck, the pill inhibits PCSK9 and cut LDL levels by up to 60 percent in a 24-week trial of 2,912 participants. It carries a list price of $315 for a 30-day supply and will reach…
dailywire.comKalshi will allow bets on selected clinical trial results and full FDA decisions, starting with Phase 3 studies from established companies. The FDA separately approved Merck's Lipfendra cholesterol pill based on studies showing up to 60% LDL reduction.